Highlights from ECTRIMS 2021 Digital Congress
On October 13-15, the 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) organized a fully digital experience…
2021 Year in Review: The MS Society of Canada is Accelerating Progress in MS Research
Through the generous support of the MS community, event participants, and donors, the Multiple Sclerosis Society of Canada has invested over $204 million…
World Mental Health Day: Multiple Sclerosis and Depression
On #WorldMentalHealthDay, we join the global conversation to raise awareness of mental health as an integral part of overall health. This article aims…
Canadian Researchers Examine the Benefits of Translingual Stimulation (PoNS) Combined with Physiotherapy in Multiple Sclerosis
Drs. Michelle Ploughman (Memorial University of Newfoundland) and Sarah Donkers (University of Saskatchewan) are set to lead the first Canadian clinical trial examining…
Indigenous People and Multiple Sclerosis
Multiple sclerosis (MS) is a disease that does not discriminate – it can affect anyone at any time, often in the prime of their lives. In…
Faces Behind the Science: Kelsi Smith
Kelsi Smith is a Canadian who is pursuing her PhD in the area of neuroscience and epidemiology at Karolinska Insitutet. In 2020, Kelsi…
New Developments in MS Research from ACTRIMS Forum 2021
The MS Society of Canada is proud to share new developments in multiple sclerosis (MS) research from the 6th annual Americas Committee for…
“Spotlight on the Future of MS Research”: endMS National Training Program
This year, the endMS National Training Program is excited to launch the 11th endMS SPRINT and 13th annual endMS Summer School competition! The…
International Day of Women and Girls in Science
In a world where only 30% of researchers are women, the MS Society is proud to report that over 60% of our funded research in 2020…
MS Society of Canada Supports New Research in MS
Through the generous support of the MS community, the Multiple Sclerosis Society of Canada has invested over $200 million in research since inception…